Non‐steroidal antiandrogen monotherapy vs LHRH agonists or surgical castration monotherapy
Treatment failure · men with advanced prostate cancer
Non‐steroidal antiandrogen monotherapy probably leads to higher treatment failure compared with LHRH agonists or surgical castration monotherapy (moderate certainty).
1 finding from 1 review
- Non‐steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical… 2014 · Cochrane Headline outcomes onlyRR 1.27 [1.05, 1.52]5 studies · 1845 participantsModerate